LTRYW
Translational Development Acquisition Corp.
NASDAQ · Consumer Cyclical · Gambling, Resorts & Casinos · US
$0.00
−23.08%Price chart
Sep 30Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29
Key dataOct 29, 2026
Open$0.00
From 52W high−93.83%
Volume705786.00
Market cap$3728.55
P/E (TTM)—
P/S (TTM)0.0x
Div yield—
Key dataOct 29, 2026
Open
$0.00
From 52W high
−93.83%
Volume
705786.00
Market cap
$3728.55
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.3x
P/E (TTM)
—
RSI (14)
33.9
MomentumView details →
1D Return
−23.08%
YTD Return
−80.39%
Similar companies
Latest newsMore news →
ProLogium and Translational Development Acquisition Corp. announced a $50 million committed primary capital investment from existing ProLogium shareholders to support their business combination that will make ProLogium a publicly listed company.99d agoTranslational Development Acquisition Company announced that ProLogium has filed an F-4 with the SEC as part of their planned de-SPAC merger.121d ago